| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.00015 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 6.8e-05 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -6.2e-05 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -1.2e-05 | 1 |